Idenix Pharmaceuticals LLC et al. v. Gilead Sciences Inc. et al., C.A. Nos. 13-1987-LPS, 14-109-LPS, 14-846-LPS, November 16, 2016.
The disputed technology relates to prodrugs used in prevention and treatment of Flaviviridae infections. The following terms were considered:The disputed technology relates to prodrugs used in prevention and treatment of Flaviviridae infections. The following terms were considered:
-
1. “method for [the] treatment of a Hepatitis C virus infection”
2. “[antivirally] effective amount”
